Conducting radiogenomic research - Do not forget careful consideration of the clinical data

Christian Nicolaj Andreassen; Gillian C. Barnett; Johannes A. Langendijk; Jan Alsner; Dirk De Ruysscher; Mechtild Krause; Soren M. Bentzen; Joanne S. Haviland; Clare Griffin; Philip Poortmans; John R. Yarnold; ESTRO GENEPI Network

doi:10.1016/j.radonc.2012.11.004

Conducting radiogenomic research - Do not forget careful consideration of the clinical data

Christian Nicolaj Andreassen^*, Gillian C. Barnett, Johannes A. Langendijk, Jan Alsner, Dirk De Ruysscher, Mechtild Krause, Soren M. Bentzen, Joanne S. Haviland, Clare Griffin, Philip Poortmans, John R. Yarnold, ESTRO GENEPI Network

^*Corresponding author voor dit werk

Onderzoeksoutput: Editorial › Academic › peer review

27 Citaten (Scopus)

Samenvatting

The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 337-340

Originele taal-2	English
Pagina's (van-tot)	337-340
Aantal pagina's	4
Tijdschrift	Radiotherapy and Oncology
Volume	105
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.1016/j.radonc.2012.11.004
Status	Published - dec.-2012

Toegang tot document

10.1016/j.radonc.2012.11.004

Handle.net

Permanente koppeling

Citeer dit

Andreassen, C. N., Barnett, G. C., Langendijk, J. A., Alsner, J., De Ruysscher, D., Krause, M., Bentzen, S. M., Haviland, J. S., Griffin, C., Poortmans, P., Yarnold, J. R., & ESTRO GENEPI Network (2012). Conducting radiogenomic research - Do not forget careful consideration of the clinical data. Radiotherapy and Oncology, 105(3), 337-340. https://doi.org/10.1016/j.radonc.2012.11.004

@article{a81f378bf2934d8d96984cf20110ce63,

title = "Conducting radiogenomic research - Do not forget careful consideration of the clinical data",

abstract = "The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 337-340",

keywords = "Normal tissue radiosensitivity, Predictive markers, Single nucleotide polymorphisms, GENOME-WIDE ASSOCIATION, NORMAL TISSUE-REACTIONS, RADIATION-THERAPY, END-POINTS, RADIOTHERAPY, TOXICITY, POLYMORPHISMS, RADIOSENSITIVITY, MECHANISMS, PATIENT",

author = "Andreassen, {Christian Nicolaj} and Barnett, {Gillian C.} and Langendijk, {Johannes A.} and Jan Alsner and {De Ruysscher}, Dirk and Mechtild Krause and Bentzen, {Soren M.} and Haviland, {Joanne S.} and Clare Griffin and Philip Poortmans and Yarnold, {John R.} and {ESTRO GENEPI Network}",

year = "2012",

month = dec,

doi = "10.1016/j.radonc.2012.11.004",

language = "English",

volume = "105",

pages = "337--340",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

number = "3",

}

Andreassen, CN, Barnett, GC, Langendijk, JA, Alsner, J, De Ruysscher, D, Krause, M, Bentzen, SM, Haviland, JS, Griffin, C, Poortmans, P, Yarnold, JR & ESTRO GENEPI Network 2012, 'Conducting radiogenomic research - Do not forget careful consideration of the clinical data', Radiotherapy and Oncology, vol. 105, nr. 3, blz. 337-340. https://doi.org/10.1016/j.radonc.2012.11.004

TY - JOUR

T1 - Conducting radiogenomic research - Do not forget careful consideration of the clinical data

AU - Andreassen, Christian Nicolaj

AU - Barnett, Gillian C.

AU - Langendijk, Johannes A.

AU - Alsner, Jan

AU - De Ruysscher, Dirk

AU - Krause, Mechtild

AU - Bentzen, Soren M.

AU - Haviland, Joanne S.

AU - Griffin, Clare

AU - Poortmans, Philip

AU - Yarnold, John R.

AU - ESTRO GENEPI Network

PY - 2012/12

Y1 - 2012/12

N2 - The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 337-340

AB - The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 337-340

KW - Normal tissue radiosensitivity

KW - Predictive markers

KW - Single nucleotide polymorphisms

KW - GENOME-WIDE ASSOCIATION

KW - NORMAL TISSUE-REACTIONS

KW - RADIATION-THERAPY

KW - END-POINTS

KW - RADIOTHERAPY

KW - TOXICITY

KW - POLYMORPHISMS

KW - RADIOSENSITIVITY

KW - MECHANISMS

KW - PATIENT

U2 - 10.1016/j.radonc.2012.11.004

DO - 10.1016/j.radonc.2012.11.004

M3 - Editorial

SN - 0167-8140

VL - 105

SP - 337

EP - 340

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 3

ER -

Conducting radiogenomic research - Do not forget careful consideration of the clinical data

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit